An Open-label, Single-dose, Randomised, Crossover Study to Evaluate Changes in the Pharmacokinetics of Ibuprofen From Ibuprofen-LDH Dosed With and Without Release Modifying Excipients in Normal, Healthy, Adult Subjects

Trial Profile

An Open-label, Single-dose, Randomised, Crossover Study to Evaluate Changes in the Pharmacokinetics of Ibuprofen From Ibuprofen-LDH Dosed With and Without Release Modifying Excipients in Normal, Healthy, Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 May 2017

At a glance

  • Drugs Ibuprofen (Primary) ; Ibuprofen lysinate
  • Indications Musculoskeletal pain
  • Focus Pharmacokinetics
  • Sponsors Oxford Pharmascience
  • Most Recent Events

    • 02 May 2017 Status changed from recruiting to completed.
    • 14 Dec 2016 Status changed from not yet recruiting to recruiting.
    • 29 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top